Literature DB >> 26054831

Antiplatelet therapy: Defining the optimal duration of DAPT after PCI with DES.

Alon Eisen1, Deepak L Bhatt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26054831     DOI： 10.1038/nrcardio.2015.87

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.

Authors:  Laura Mauri; Dean J Kereiakes; Robert W Yeh; Priscilla Driscoll-Shempp; Donald E Cutlip; P Gabriel Steg; Sharon-Lise T Normand; Eugene Braunwald; Stephen D Wiviott; David J Cohen; David R Holmes; Mitchell W Krucoff; James Hermiller; Harold L Dauerman; Daniel I Simon; David E Kandzari; Kirk N Garratt; David P Lee; Thomas K Pow; Peter Ver Lee; Michael J Rinaldi; Joseph M Massaro
Journal:  N Engl J Med       Date:  2014-11-16       Impact factor: 91.245

2.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

Authors:  Glenn N Levine; Eric R Bates; James C Blankenship; Steven R Bailey; John A Bittl; Bojan Cercek; Charles E Chambers; Stephen G Ellis; Robert A Guyton; Steven M Hollenberg; Umesh N Khot; Richard A Lange; Laura Mauri; Roxana Mehran; Issam D Moussa; Debabrata Mukherjee; Brahmajee K Nallamothu; Henry H Ting
Journal:  J Am Coll Cardiol       Date:  2011-11-07       Impact factor: 24.094

3.  2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Authors:  Stephan Windecker; Philippe Kolh; Fernando Alfonso; Jean-Philippe Collet; Jochen Cremer; Volkmar Falk; Gerasimos Filippatos; Christian Hamm; Stuart J Head; Peter Jüni; A Pieter Kappetein; Adnan Kastrati; Juhani Knuuti; Ulf Landmesser; Günther Laufer; Franz-Josef Neumann; Dimitrios J Richter; Patrick Schauerte; Miguel Sousa Uva; Giulio G Stefanini; David Paul Taggart; Lucia Torracca; Marco Valgimigli; William Wijns; Adam Witkowski
Journal:  Eur Heart J       Date:  2014-08-29       Impact factor: 29.983

4.  Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction.

Authors:  Robert W Yeh; Dean J Kereiakes; Philippe Gabriel Steg; Stephan Windecker; Michael J Rinaldi; Anthony H Gershlick; Donald E Cutlip; David J Cohen; Jean-Francois Tanguay; Alice Jacobs; Stephen D Wiviott; Joseph M Massaro; Adrian C Iancu; Laura Mauri
Journal:  J Am Coll Cardiol       Date:  2015-03-15       Impact factor: 24.094

Review 5.  Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis.

Authors:  Tullio Palmerini; Diego Sangiorgi; Marco Valgimigli; Giuseppe Biondi-Zoccai; Fausto Feres; Alexandre Abizaid; Ricardo A Costa; Myeong-Ki Hong; Byeong-Keuk Kim; Yangsoo Jang; Hyo-Soo Kim; Kyung Woo Park; Andrea Mariani; Diego Della Riva; Philippe Genereux; Martin B Leon; Deepak L Bhatt; Umberto Bendetto; Claudio Rapezzi; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2015-03-24       Impact factor: 24.094

Review 6.  Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials.

Authors:  Tullio Palmerini; Umberto Benedetto; Letizia Bacchi-Reggiani; Diego Della Riva; Giuseppe Biondi-Zoccai; Fausto Feres; Alexandre Abizaid; Myeong-Ki Hong; Byeong-Keuk Kim; Yangsoo Jang; Hyo-Soo Kim; Kyung Woo Park; Philippe Genereux; Deepak L Bhatt; Carlotta Orlandi; Stefano De Servi; Mario Petrou; Claudio Rapezzi; Gregg W Stone
Journal:  Lancet       Date:  2015-03-14       Impact factor: 79.321

7.  Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.

Authors:  Deepak L Bhatt; Keith A A Fox; Werner Hacke; Peter B Berger; Henry R Black; William E Boden; Patrice Cacoub; Eric A Cohen; Mark A Creager; J Donald Easton; Marcus D Flather; Steven M Haffner; Christian W Hamm; Graeme J Hankey; S Claiborne Johnston; Koon-Hou Mak; Jean-Louis Mas; Gilles Montalescot; Thomas A Pearson; P Gabriel Steg; Steven R Steinhubl; Michael A Weber; Danielle M Brennan; Liz Fabry-Ribaudo; Joan Booth; Eric J Topol
Journal:  N Engl J Med       Date:  2006-03-12       Impact factor: 91.245

Review 8.  Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis.

Authors:  Anthony A Bavry; Deepak L Bhatt
Journal:  Lancet       Date:  2008-06-21       Impact factor: 79.321

9.  Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.

Authors:  Sripal Bangalore; Sunil Kumar; Mario Fusaro; Nicholas Amoroso; Michael J Attubato; Frederick Feit; Deepak L Bhatt; James Slater
Journal:  Circulation       Date:  2012-05-14       Impact factor: 29.690

10.  Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials.

Authors:  Eliano Pio Navarese; Felicita Andreotti; Volker Schulze; Michalina Kołodziejczak; Antonino Buffon; Marc Brouwer; Francesco Costa; Mariusz Kowalewski; Gianfranco Parati; Gregory Y H Lip; Malte Kelm; Marco Valgimigli
Journal:  BMJ       Date:  2015-04-16
  10 in total
  1 in total

Review 1.  Duration of Dual Antiplatelet Therapy in Coronary Artery Disease: a Review Article.

Authors:  Alex D Moseley; Fareed M Collado; Annabelle Santos Volgman; Gary L Schaer; R Jeffrey Snell
Journal:  Curr Atheroscler Rep       Date:  2016-07       Impact factor: 5.113
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.